Opportunity Information: Apply for CDC RFA PS10 1037

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Building capacity of the Pasteur Institute to provide quality laboratory diagnosis and surveillance of opportunistic infections related to HIV in the Republic of Cote dIvoire under the President s Emergency Plan for AIDS Relief" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
  • This funding opportunity was created on Dec 30, 2009 and posted on Dec 29, 2009.
  • Applicants must submit their applications by Mar 2, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $85,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • The Pasteur Institute of Cote d Ivoire (IPCI) is uniquely qualified to fulfill the requirements set forth in this funding opportunity announcement. In 2006, the IPCI was designated the laboratory institution in charge of Integrated Disease Surveillance and Response (IDSR) in Cote d Ivoire by the MOH and Ministry of Scientific Research. Under this mandate IPCI is responsible for the implementation, monitoring, and evaluation of population based TB, malaria and epidemic disease surveillance, including HIV opportunistic infections, as well as prevention and care policies and interventions.
Apply for CDC RFA PS10 1037

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

This funding opportunity (CDC RFA PS10-1037) is a CDC cooperative agreement issued under the President's Emergency Plan for AIDS Relief (PEPFAR) focused on strengthening HIV/AIDS-related laboratory services in the Republic of Cote d'Ivoire, with a particular emphasis on diagnosing and tracking opportunistic infections like tuberculosis (TB). The central purpose is to build lasting capacity across the national laboratory network so that patients and clinicians can rely on accurate, timely, and widely available testing, and so that public health authorities can use better laboratory data to monitor disease trends and respond effectively.

The award is designed around the Pasteur Institute of Cote d'Ivoire (IPCI) serving as the key implementing partner and capacity-building hub. IPCI is described as uniquely qualified because it was designated in 2006 by the Ministry of Health and the Ministry of Scientific Research as the institution responsible for Integrated Disease Surveillance and Response (IDSR) in Cote d'Ivoire. Under that mandate, IPCI already has a national role in implementing, monitoring, and evaluating population-based surveillance for TB, malaria, epidemic-prone diseases, and HIV-related opportunistic infections, as well as supporting prevention and care policies. This grant leverages that existing responsibility and expands IPCI's ability to carry out high-quality laboratory diagnosis and surveillance at scale.

Operationally, the project emphasizes coordination and system-building rather than isolated improvements at a single site. IPCI is expected to collaborate closely with multiple Ministry of Health sub-departments and central laboratories, the CDC Retro CI laboratory, the National Public Health Laboratory (LNSP), the TB laboratory network, and at least 19 regional hospitals. The intent is to improve how laboratory activities are coordinated and implemented nationwide, including standardizing practices, improving the flow and quality of laboratory data, and strengthening connections between reference-level laboratories and regional facilities that serve patients directly.

The expected impact is broad and practical. On the service delivery side, the award aims to directly increase the quality and availability of laboratory testing throughout the country for HIV/AIDS-related opportunistic infections, especially TB, which remains a major driver of illness and death among people living with HIV. On the surveillance side, it is meant to strengthen the ability to track opportunistic infections through improved laboratory-based surveillance systems, producing better data that can inform program decisions, outbreak detection, and resource allocation. The opportunity also highlights infrastructure and workforce development, meaning upgrades to lab systems and equipment where needed, and strengthening human resource capacity through training, mentoring, and improved laboratory management practices.

A separate but related objective is to reinforce IPCI's standing as a reference laboratory capable of participating in national and international public health evaluations. In practice, this usually implies improving quality systems, adopting recognized standards, strengthening proficiency testing and external quality assessment participation, and ensuring IPCI can credibly support evaluations that compare performance across sites or validate diagnostic approaches.

From an administrative standpoint, this is a discretionary grant using a cooperative agreement mechanism, signaling that CDC expects substantial involvement in the implementation through technical collaboration rather than simply providing funds and receiving reports. The opportunity was posted December 29, 2009, with an application closing date of March 2, 2010, and it was archived April 1, 2010. The listing notes an estimated total funding amount of $85,000,000, while indicating an award floor of $500,000 and an award ceiling of $1,000,000, with one expected award. Cost sharing or matching is not required. Eligibility is effectively restricted to IPCI, with the announcement stating IPCI is uniquely qualified to meet the requirements described.

For questions or access issues related to the full announcement, the contact listed is PGO TIMS Grants at 770-488-2700.

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This opportunity is CDC RFA PS10-1037, a CDC cooperative agreement issued under the President's Emergency Plan for AIDS Relief (PEPFAR). It focuses on strengthening HIV/AIDS-related laboratory services in the Republic of Cote d'Ivoire, with particular emphasis on diagnosing and tracking opportunistic infections such as tuberculosis (TB).

What is the main goal of the award?

The central purpose is to build lasting capacity across the national laboratory network so patients and clinicians can rely on accurate, timely, and widely available testing, and so public health authorities can use improved laboratory data to monitor disease trends and respond effectively.

Which country and health area does the project target?

The project targets the Republic of Cote d'Ivoire and focuses on laboratory services linked to HIV/AIDS, especially laboratory diagnosis and surveillance for opportunistic infections like TB.

Which organization is intended to lead implementation?

The Pasteur Institute of Cote d'Ivoire (IPCI) is designated as the key implementing partner and capacity-building hub for this award.

Why is IPCI considered uniquely qualified for this award?

IPCI is described as uniquely qualified because it was designated in 2006 by the Ministry of Health and the Ministry of Scientific Research as the institution responsible for Integrated Disease Surveillance and Response (IDSR) in Cote d'Ivoire. Under that mandate, IPCI already has a national role in implementing, monitoring, and evaluating population-based surveillance for TB, malaria, epidemic-prone diseases, and HIV-related opportunistic infections, and in supporting prevention and care policies.

Is eligibility open to multiple organizations?

No. Eligibility is effectively restricted to IPCI. The announcement states IPCI is uniquely qualified to meet the requirements described.

What kind of grant mechanism is used?

This is a discretionary grant using a cooperative agreement mechanism, which signals that CDC expects substantial involvement in implementation through technical collaboration rather than only providing funds and receiving reports.

What does the cooperative agreement structure imply for CDC's role?

Based on the listing, CDC is expected to be substantially involved through technical collaboration during implementation, consistent with how cooperative agreements differ from more hands-off funding arrangements.

What are the main programmatic priorities described in the opportunity?

The opportunity prioritizes system-building and nationwide coordination of laboratory services, improvement of laboratory diagnosis for HIV-related opportunistic infections (especially TB), strengthening laboratory-based surveillance systems, and supporting infrastructure and workforce development through training, mentoring, and improved laboratory management practices.

Is the project focused on a single laboratory site or a national network?

The project emphasizes coordination and system-building across the national laboratory network, rather than isolated improvements at a single site.

Which partners and facilities are mentioned for collaboration?

IPCI is expected to collaborate closely with multiple Ministry of Health sub-departments and central laboratories, the CDC Retro CI laboratory, the National Public Health Laboratory (LNSP), the TB laboratory network, and at least 19 regional hospitals.

What improvements to laboratory services are expected?

The award aims to increase the quality and availability of laboratory testing throughout Cote d'Ivoire for HIV/AIDS-related opportunistic infections, with a particular focus on TB.

How does the opportunity address surveillance and public health monitoring?

It is meant to strengthen the ability to track opportunistic infections through improved laboratory-based surveillance systems, producing better data to inform program decisions, outbreak detection, and resource allocation.

What does the opportunity say about laboratory data?

It emphasizes improving the flow and quality of laboratory data and strengthening how laboratory activities are coordinated and implemented nationwide, including standardizing practices.

Does the opportunity include workforce development?

Yes. The opportunity highlights strengthening human resource capacity through training, mentoring, and improved laboratory management practices.

Does the opportunity mention infrastructure or equipment upgrades?

Yes. It references infrastructure development, including upgrades to lab systems and equipment where needed, as part of strengthening the laboratory network.

What is the role of IPCI as a reference laboratory under this award?

A separate but related objective is to reinforce IPCI's standing as a reference laboratory capable of participating in national and international public health evaluations.

What types of quality improvements are implied for IPCI's reference laboratory role?

The description suggests strengthening quality systems, adopting recognized standards, improving proficiency testing, increasing participation in external quality assessment activities, and ensuring IPCI can credibly support evaluations that compare performance across sites or validate diagnostic approaches.

When was the opportunity posted and when did it close?

The opportunity was posted on December 29, 2009, and the application closing date was March 2, 2010.

Is the opportunity still active?

No. The listing indicates it was archived on April 1, 2010.

How many awards were expected?

One award was expected.

What funding amounts are mentioned?

The listing notes an estimated total funding amount of $85,000,000. It also indicates an award floor of $500,000 and an award ceiling of $1,000,000, with one expected award.

Is cost sharing or matching required?

No. Cost sharing or matching is not required.

Who should be contacted for questions or access issues related to the full announcement?

For questions or access issues related to the full announcement, the contact listed is PGO TIMS Grants at 770-488-2700.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Integrative Graduate Education and Research Traineeship Program

Previous opportunity: Measurement Science and Engineering (MSE) Research Grants Programs

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA PS10 1037

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA PS10 1037) also looked into and applied for these:

Funding Opportunity
Advanced Education Nursing Grants Apply for HRSA 10 065

Funding Number: HRSA 10 065
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
National Resource Center for Hearing Screening and Intervention in Newborns Apply for HRSA 10 059

Funding Number: HRSA 10 059
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Coordinated Orphans and Vulnerable Children Care Program Apply for USAID TANZANIA 10 004 RFA

Funding Number: USAID TANZANIA 10 004 RFA
Agency: Tanzania USAID Dar es Salaam
Category: Health
Funding Amount: $11,800,000
Leadership Education in Maternal and Child Public Health (MCH PH) Apply for HRSA 10 108

Funding Number: HRSA 10 108
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Partnership for State Title V MCH Leadership Community Apply for HRSA 10 032

Funding Number: HRSA 10 032
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Healthy Passages A Community based Longitudinal Study of Adolescent Health (U19) Apply for CDC RFA DP10 007

Funding Number: CDC RFA DP10 007
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,100,000
Technology Development for High Throughput Structural Biology Research (P01) Apply for PAR 10 074

Funding Number: PAR 10 074
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technology Development for High Throughput Structural Biology Research (R01) Apply for PAR 10 073

Funding Number: PAR 10 073
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Consumer and Consumer Supporter Technical Assistance Centers Apply for SM 10 008

Funding Number: SM 10 008
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $330,000
Access to Recovery Apply for TI 10 008

Funding Number: TI 10 008
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $4,000,000
Epidemiologic Study of Inflammatory Bowel Disease (U 01) Apply for RFA DP 10 006

Funding Number: RFA DP 10 006
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
StrengtheningTB and HIV/AIDS Response in the South Western Region of Uganda (STAR SW) Apply for USAID UGANDA RFA 617 10 00003

Funding Number: USAID UGANDA RFA 617 10 00003
Agency: Uganda USAID Kampala
Category: Health
Funding Amount: $50,000,000
Healthy Passages A Community based Longitudinal Study of Adolescent Health (U19) Apply for RFA DP 10 007

Funding Number: RFA DP 10 007
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,100,000
Technology Development for Protein Modeling (P01) Apply for PAR 10 075

Funding Number: PAR 10 075
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technology Development for Protein Modeling (R01) Apply for PAR 10 076

Funding Number: PAR 10 076
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Translating Research into Healthy Eye and Vision Loss Prevention (U58) Apply for RFA DP 10 004

Funding Number: RFA DP 10 004
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $300,000
Recovery Act Limited Competition NIH Basic Behavioral and Social Science Opportunity Network (OppNet) Short term Mentored Career Development Awards in the Basic Behavioral and Social Sciences for Mid career and Senior Investigators (K18) Apply for RFA OD 10 003

Funding Number: RFA OD 10 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Supporting the National Blood Transfusion Service in the Implementation and Expansion of Blood Safety Activities in the Republic of Cte d Ivoire under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS10 1035

Funding Number: CDC RFA PS10 1035
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $6,000,000
Support to the Government of the Kingdom of Lesotho (GOL) to Strengthen and Expand Safe Blood Transfusion Services Apply for CDC RFA PS10 1050

Funding Number: CDC RFA PS10 1050
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Supporting the National Blood Transfusion Service in the Implementation and Expansion of Blood Safety Activities in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10106

Funding Number: CDC RFA PS10 10106
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1037", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.